Pancreatic Cancer Research

ResearcherInsermActive in the last 2 years

Jules Grégory

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6081-1663; OpenAlex author ID A5049403746. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2026: 3 papers

Papers 3

  1. Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver Injury and Postoperative… Co-author DOI 10.1245/s10434-026-19545-w↗
  2. ASO Visual Abstract: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver Inj… Co-author DOI 10.1245/s10434-026-19641-x↗
  3. ASO Author Reflections: Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver … Co-author DOI 10.1245/s10434-026-19683-1↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Farha Tessier · 3 shared papers, 2026 · strength 0.84
  2. Maxime Ronot · 3 shared papers, 2026 · strength 0.84
  3. Alain Sauvanet · 3 shared papers, 2026 · strength 0.84
  4. Tatiana Codjia · 3 shared papers, 2026 · strength 0.84

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.